{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:29:30Z","timestamp":1790501370226,"version":"4.1.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.lpm.2014.03.027","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T16:21:34Z","timestamp":1409415694000},"page":"e315-e328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"P2","title":["Musculoskeletal involvement in systemic sclerosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Veronika","family":"L\u00f3r\u00e1nd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Czirj\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcnde","family":"Minier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.03.027_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.1780210111","article-title":"Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations","volume":"21","author":"Clements","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.1780250110","article-title":"Electromyographic findings in various forms of progressive systemic sclerosis","volume":"25","author":"Hausmanowa-Petrusewicz","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/03009741003774626","article-title":"Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features","volume":"39","author":"Ranque","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.lpm.2014.03.027_bib0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/art.1780110405","article-title":"Skeletal muscle involvement in progressive systemic sclerosis (scleroderma)","volume":"11","author":"Medsger","year":"1968","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.28.3.281","article-title":"Skeletal muscle involvement in systemic sclerosis","volume":"28","author":"Thompson","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-4362.1987.tb00580.x","article-title":"Scleroderma-polymyositis overlap syndrome. Clinical and serologic aspects","volume":"26","author":"Mimori","year":"1987","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1961.01580150005001","article-title":"Systemic scleroderma. A clinical study of 727 cases","volume":"84","author":"Tuffanelli","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/art.1780240506","article-title":"Association of myositis and myocarditis in progressive systemic sclerosis","volume":"24","author":"West","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3899\/jrheum.121380","article-title":"The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review","volume":"40","author":"Muangchan","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0060","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.1780390712","article-title":"Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-004-0975-7","article-title":"Clinical and laboratory features of scleroderma patients developing skeletal myopathy","volume":"24","author":"Mimura","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/38.5.397","article-title":"Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans","volume":"38","author":"Tager","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.lpm.2014.03.027_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0080","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1001\/archinte.1990.00390230098013","article-title":"Muscle involvement in the scleroderma syndromes","volume":"150","author":"Ringel","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2014.03.027_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2014.03.027_bib0090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780400421","article-title":"Racial differences in scleroderma among women in Michigan","volume":"40","author":"Laing","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0095","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.34482","article-title":"A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis","volume":"64","author":"Steen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0105","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2008.095919","article-title":"A descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0115","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0120","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/1529-0131(199911)42:11<2372::AID-ANR16>3.0.CO;2-J","article-title":"Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0733-8619(18)30804-1","article-title":"Neurologic manifestations of rheumatologic disease","volume":"7","author":"Brick","year":"1989","journal-title":"Neurol Clin"},{"key":"10.1016\/j.lpm.2014.03.027_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2010.02.015","article-title":"Dropped head syndrome as a presenting sign of scleromyositis","volume":"292","author":"Garcin","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2014.03.027_bib0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/CND.0b013e3181c139f6","article-title":"Paraspinal and scapular myopathy associated with scleroderma","volume":"11","author":"Rojana-Udomsart","year":"2010","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2008.10.013","article-title":"Dropped head syndrome and systemic sclerosis","volume":"76","author":"Rosato","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2014.03.027_bib0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0150","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0160","series-title":"EULAR Textbook on Systemic Sclerosis","first-page":"265","author":"Maurer","year":"2013"},{"key":"10.1016\/j.lpm.2014.03.027_bib0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2014.03.027_bib0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0175","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/ard.2007.073981","article-title":"Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study","volume":"67","author":"Rozman","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0180","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780350114","article-title":"Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis","volume":"35","author":"Okano","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0190","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.lpm.2014.03.027_bib0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00330-012-2584-1","article-title":"Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms","volume":"23","author":"Schanz","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0205","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar4047","article-title":"Impaired skeletal muscle microcirculation in systemic sclerosis","volume":"14","author":"Partovi","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2014.03.027_bib0210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jmri.24046","article-title":"Correlation of muscle BOLD MRI with transcutaneous oxygen pressure for assessing microcirculation in patients with systemic sclerosis","volume":"38","author":"Partovi","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.lpm.2014.03.027_bib0215","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","article-title":"Neurologic manifestations of progressive systemic sclerosis","volume":"49","author":"Averbuch-Heller","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0220","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/mus.880161110","article-title":"Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma)","volume":"16","author":"Hietaharju","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2014.03.027_bib0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2014.03.027_bib0235","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2014.03.027_bib0240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1422.029","article-title":"Systemic sclerosis-associated myopathy","volume":"1108","author":"Ranque","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2014.03.027_bib0245","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/art.24734","article-title":"Clinical and genetic factors predictive of mortality in early systemic sclerosis","volume":"61","author":"Assassi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0250","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","article-title":"Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature","volume":"92","author":"Gelber","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2014.03.027_bib0260","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar2965","article-title":"B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial","volume":"12","author":"Bosello","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2014.03.027_bib0265","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/acr.20320","article-title":"Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study","volume":"62","author":"Au","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lpm.2014.03.027_bib0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12016-009-8191-5","article-title":"Scleroderma renal crisis: a rare but severe complication of systemic sclerosis","volume":"40","author":"Mouthon","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0275","first-page":"157","article-title":"Glucocorticoids in systemic sclerosis: weighing the benefits and risks\u00a0\u2013\u00a0a systematic review","volume":"31","author":"Iudici","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0280","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/annrheumdis-2012-202657","article-title":"Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study","volume":"72","author":"Elhai","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0285","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ard.41.2.147","article-title":"The articular manifestations of progressive systemic sclerosis (scleroderma)","volume":"41","author":"Baron","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0295","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/art.1780240702","article-title":"The arthropathy of advanced progressive systemic sclerosis. A radiographic survey","volume":"24","author":"Blocka","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0300","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/sarh.2002.29493","article-title":"Foot involvement in systemic sclerosis: a longitudinal study of 100 patients","volume":"31","author":"La Montagna","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00256-004-0830-6","article-title":"The arthropathy of systemic sclerosis: a 12-month prospective clinical and imaging study","volume":"34","author":"La Montagna","year":"2005","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0310","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2458-7-260","article-title":"Erosive arthropathy in systemic sclerosis","volume":"7","author":"Allali","year":"2007","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lpm.2014.03.027_bib0315","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2214\/ajr.136.6.1121","article-title":"Skeletal findings in progressive systemic sclerosis (scleroderma)","volume":"136","author":"Bassett","year":"1981","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0320","first-page":"197","article-title":"Mandibular function is severely impaired in systemic sclerosis patients","volume":"24","author":"Ferreira","year":"2010","journal-title":"J Orofac Pain"},{"key":"10.1016\/j.lpm.2014.03.027_bib0325","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijom.2011.02.026","article-title":"Temporomandibular joint involvement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis","volume":"40","author":"Aliko","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.lpm.2014.03.027_bib0330","first-page":"1073","article-title":"Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions","volume":"35","author":"Yuen","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02208027","article-title":"Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause","volume":"10","author":"La Montagna","year":"1991","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0340","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/ard.2003.011064","article-title":"Bone mineral density in patients with systemic sclerosis","volume":"63","author":"Frediani","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0345","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03009740600704296","article-title":"Systemic sclerosis and bone loss: the role of the disease and body composition","volume":"35","author":"Souza","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0350","first-page":"180","article-title":"Prognostic factors of low bone mineral density in systemic sclerosis","volume":"23","author":"Sampaio-Barros","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0355","first-page":"313","article-title":"Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis","volume":"22","author":"Frediani","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0360","first-page":"1822","article-title":"Osteoporosis\u00a0\u2013\u00a0less than expected in patients with scleroderma?","volume":"27","author":"Neumann","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0365","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/acr.21761","article-title":"Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis","volume":"64","author":"Avouac","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0370","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3899\/jrheum.130032","article-title":"Low bone density in systemic sclerosis. A systematic review","volume":"40","author":"Omair","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0375","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10067-006-0313-3","article-title":"Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis","volume":"26","author":"Ingegnoli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0380","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jbspin.2007.06.014","article-title":"Indices of the Scleroderma Assessment Questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time","volume":"75","author":"Ostojic","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2014.03.027_bib0385","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10067-005-0041-0","article-title":"Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis","volume":"25","author":"Ostojic","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0390","first-page":"359","article-title":"Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis","volume":"34","author":"Malcarne","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0395","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/art.22468","article-title":"Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey","volume":"57","author":"Rannou","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0400","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.23819","article-title":"Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey","volume":"59","author":"Mouthon","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0405","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1590\/S1516-31802011000500012","article-title":"Hand dysfunction in scleroderma patients","volume":"129","author":"Skare","year":"2011","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.lpm.2014.03.027_bib0410","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/rheumatology\/kep464","article-title":"Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial","volume":"49","author":"Khanna","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0415","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.24380","article-title":"Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0420","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.21668","article-title":"Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings","volume":"64","author":"Elhai","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0425","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1002\/art.24986","article-title":"Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study","volume":"60","author":"Su","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0430","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ejim.2011.09.010","article-title":"Arthritis in patients with systemic sclerosis","volume":"23","author":"Schmeiser","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lpm.2014.03.027_bib0435","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/1529-0131(200103)44:3<653::AID-ANR114>3.0.CO;2-Q","article-title":"The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial","volume":"44","author":"Clements","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0440","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.2005.044602","article-title":"Radiological hand involvement in systemic sclerosis","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0445","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semarthrit.2007.03.008","article-title":"The impact of psychological functioning upon systemic sclerosis patients\u2019 quality of life","volume":"37","author":"Hyphantis","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0450","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jbspin.2007.07.017","article-title":"The \u201csclerodermic hand\u201d: a radiological and clinical study","volume":"75","author":"Erre","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2014.03.027_bib0455","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/kem021","article-title":"Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity","volume":"46","author":"Szucs","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0460","first-page":"91","article-title":"Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis","volume":"21","author":"Jinnin","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0465","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/34.9.831","article-title":"Arthritis in scleroderma","volume":"34","author":"Misra","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0470","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kep250","article-title":"Ultrasonographic features of the hand and wrist in systemic sclerosis","volume":"48","author":"Cuomo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0475","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0480","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2298\/SARH1206350S","article-title":"The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis","volume":"140","author":"Stamenkovic","year":"2012","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.lpm.2014.03.027_bib0485","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s00296-011-2205-3","article-title":"Evaluating hand in systemic sclerosis","volume":"32","author":"Arslan Tas","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.lpm.2014.03.027_bib0490","first-page":"542","article-title":"Anti-cyclic citrullinated peptide antibody in systemic sclerosis","volume":"26","author":"Morita","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0495","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kep138","article-title":"Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement","volume":"48","author":"Generini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0500","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/rheumatology\/keq205","article-title":"Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis","volume":"49","author":"Ueda-Hayakawa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0505","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3899\/jrheum.080795","article-title":"Magnetic resonance imaging of the hand in systemic sclerosis","volume":"36","author":"Low","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0510","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/rheumatology\/keq268","article-title":"Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia","volume":"49","author":"Chitale","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0515","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/ard.2006.060111","article-title":"Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study","volume":"66","author":"Nacci","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.lpm.2014.03.027_bib0520","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"69","author":"Smolen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0525","first-page":"S58","article-title":"Quantitative joint assessment in rheumatoid arthritis","volume":"23","author":"Sokka","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0530","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.22734","article-title":"Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis","volume":"56","author":"Allanore","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0535","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.2010.134304","article-title":"Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0540","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1148\/radiol.13121994","article-title":"Hand and wrist involvement in systemic sclerosis: US features","volume":"269","author":"Freire","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.lpm.2014.03.027_bib0545","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semarthrit.2010.06.008","article-title":"Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations","volume":"40","author":"Koutaissoff","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0550","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/rheumatology\/38.6.535","article-title":"Development and validation of a self-administered systemic sclerosis questionnaire (SySQ)","volume":"38","author":"Ruof","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0555","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/03009747909114448","article-title":"Joint involvement in systemic sclerosis","volume":"8","author":"Lovell","year":"1979","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0560","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2340\/0001555563349352","article-title":"Radiological changes of the hands in systemic sclerosis","volume":"63","author":"Brun","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0565","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0570","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0575","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.027_bib0580","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.22580","article-title":"Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study","volume":"56","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0585","first-page":"1636","article-title":"Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease","volume":"34","author":"Lam","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0590","first-page":"S55","article-title":"Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis","volume":"30","author":"Omair","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0595","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2008.096123","article-title":"An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis","volume":"68","author":"Denton","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0600","first-page":"S40","article-title":"Is there a role for TNFalpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique","volume":"29","author":"Distler","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0605","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jassh.2004.11.006","article-title":"Scleroderma of the hand","volume":"5","author":"Jakubietz","year":"2005","journal-title":"J Am Soc Surg Hand"},{"key":"10.1016\/j.lpm.2014.03.027_bib0610","first-page":"81","article-title":"The rheumatic manifestations of progressive systemic sclerosis (scleroderma)","volume":"57","author":"Rodnan","year":"1968","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.lpm.2014.03.027_bib0615","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780400620","article-title":"The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0620","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/kes307","article-title":"Tendon friction rubs in systemic sclerosis: a possible explanation\u00a0\u2013\u00a0an ultrasound and magnetic resonance imaging study","volume":"52","author":"Stoenoiu","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0625","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/acr.21964","article-title":"Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis","volume":"65","author":"Dore","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0630","first-page":"1117","article-title":"Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0635","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.semarthrit.2011.10.003","article-title":"Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis","volume":"41","author":"Clements","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.027_bib0640","first-page":"167","article-title":"The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation","volume":"30","author":"Bruce","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0645","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2005.050187","article-title":"Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study","volume":"65","author":"Khanna","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0650","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","article-title":"European Scleroderma Study Group to define disease activity criteria for systemic sclerosis III. Assessment of the construct validity of the preliminary activity criteria","volume":"62","author":"Valentini","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0655","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.62.9.904","article-title":"European Scleroderma Study Group to define disease activity criteria for systemic sclerosis IV. Assessment of skin thickening by modified Rodnan skin score","volume":"62","author":"Valentini","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.027_bib0660","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/rheumatology\/keq022","article-title":"Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis","volume":"49","author":"Minier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0665","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.21716","article-title":"Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group","volume":"64","author":"Muangchan","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.027_bib0670","first-page":"1586","article-title":"The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis","volume":"33","author":"Mugii","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0675","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1519\/JSC.0b013e3181d6858b","article-title":"Efficacy and safety of concurrent training in systemic sclerosis","volume":"25","author":"Pinto","year":"2011","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.lpm.2014.03.027_bib0680","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/rheumatology\/22.4.224","article-title":"Objective evaluation of hand function in scleroderma patients to assess effectiveness of physical therapy","volume":"22","author":"Askew","year":"1983","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0685","first-page":"19","article-title":"Paraffin hand bath for scleroderma","volume":"1","author":"Pils","year":"1991","journal-title":"Phys Med Rehabil"},{"key":"10.1016\/j.lpm.2014.03.027_bib0690","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/09638280410001702405","article-title":"Evaluation of paraffin bath treatment in patients with systemic sclerosis","volume":"26","author":"Sandqvist","year":"2004","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.lpm.2014.03.027_bib0695","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10067-009-1216-x","article-title":"Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis","volume":"28","author":"Bongi","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0700","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/acr.20487","article-title":"Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase","volume":"63","author":"Bongi","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lpm.2014.03.027_bib0705","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5014\/ajot.41.2.118","article-title":"Effects of splinting in the treatment of hand contractures in progressive systemic sclerosis","volume":"41","author":"Seeger","year":"1987","journal-title":"Am J Occup Ther"},{"key":"10.1016\/j.lpm.2014.03.027_bib0710","first-page":"44","article-title":"Efficacy of a tailored rehabilitation program for systemic sclerosis","volume":"27","author":"Maddali Bongi","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.027_bib0715","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/acr.20448","article-title":"Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis","volume":"63","author":"Schouffoer","year":"2011","journal-title":"Arthritis Care Res"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214003388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214003388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T23:41:48Z","timestamp":1717285308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214003388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0755498214003388"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.027","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Musculoskeletal involvement in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.08.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.02.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.08.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.06.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.08.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.01.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}